Aoki Drug Holdings, Inc. announced that it has resolved to propose the appointment of 11 directors and 1 substitute statutory auditor as agenda items at the 28th Annual General Meeting of Shareholders scheduled for August 19, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3549","jir_company_name":"Aoki Drug Holdings, Inc.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-07-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/3549-20260716-01.pdf","jir_short_summary":"Aoki Drug Holdings, Inc. announced that it has resolved to propose the appointment of 11 directors and 1 substitute statutory auditor as agenda items at the 28th Annual General Meeting of Shareholders scheduled for August 19, 2026.","jir_summary":"### Overview of Agenda Items\nAoki Drug Holdings, Inc. has resolved to submit proposals for the appointment of 11 directors and 1 substitute statutory auditor at the Annual General Meeting of Shareholders scheduled for August 19, 2026. Details are provided in related materials dated July 16, 2026.\n\n### Impact on Shareholders and Future Plans\nThis agenda pertains to management personnel changes and aims to stabilize the management structure through shareholder voting. Details of the proposals and candidate information have been separately disclosed, and shareholders may participate either by attending the meeting or exercising voting rights.","jir_financial_highlights":"","jir_category":"","jir_hashtags":"#AokiDrugHoldings, #IR, #JapaneseStocks","jir_key_figures":"Agenda proposal: Appointment of 11 directors\nSubstitute statutory auditor: 1 appointment\nMeeting date: August 19, 2026","jir_meta_title":"\u3010Aoki Drug Holdings\u3011Notice of Agenda for the Annual General Meeting of Shareholders | August 19, 2026","jir_meta_description":"Aoki Drug Holdings has resolved the agenda proposal to elect 11 directors and 1 substitute statutory auditor at the Annual General Meeting scheduled for August 19, 2026. Please refer to the materials for details.","jir_og_title":"\u3010Aoki Drug\u3011Shareholders Meeting Agenda Notice | August 19, 2026","jir_og_description":"Aoki Drug will propose the appointment of directors and auditors at the shareholders meeting on August 19, 2026. Please check the details.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8062,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-81834","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n